Fibroblast Growth Factor 21 (FGF21) Administration Sex-Specifically Affects Blood Insulin Levels and Liver Steatosis in Obese <i>A<sup>y</sup></i> Mice
FGF21 is a promising candidate for treating obesity, diabetes, and NAFLD; however, some of its pharmacological effects are sex-specific in mice with the <i>A<sup>y</sup></i> mutation that evokes melanocortin receptor 4 blockade, obesity, and hepatosteatosis. This suggests tha...
Main Authors: | Elena Makarova, Antonina Kazantseva, Anastasia Dubinina, Elena Denisova, Tatiana Jakovleva, Natalia Balybina, Nataliya Bgatova, Konstantin Baranov, Nadezhda Bazhan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/10/12/3440 |
Similar Items
-
Genetic Obesity in Pregnant <i>A<sup>y</sup></i> Mice Does Not Affect Susceptibility to Obesity and Food Choice in Offspring
by: Elena Makarova, et al.
Published: (2023-03-01) -
The Same Metabolic Response to FGF21 Administration in Male and Female Obese Mice Is Accompanied by Sex-Specific Changes in Adipose Tissue Gene Expression
by: Elena Makarova, et al.
Published: (2021-09-01) -
Estradiol-dependent and independent effects of FGF21 in obese female mice
by: T. V. Jakovleva, et al.
Published: (2022-04-01) -
Embracing [XY<sub>3</sub>]<i><sup>m–</sup></i> and [XY<sub>4</sub>]<i><sup>m–</sup></i> Anions in Salts of [M(bpy)<sub>3</sub>]<i><sup>q</sup></i><sup>+</sup>
by: Edwin C. Constable, et al.
Published: (2023-01-01) -
Influence of <i>Clear<sup>T</sup></i> and <i>Clear<sup>T2</sup></i> Agitation Conditions in the Fluorescence Imaging of 3D Spheroids
by: Daniel N. Silva, et al.
Published: (2020-12-01)